» Articles » PMID: 22142811

Differentiation-promoting Culture of Competent and Noncompetent Keratinocytes Identifies Biomarkers for Head and Neck Cancer

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2011 Dec 7
PMID 22142811
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant contact-inhibited proliferation and differentiation induction couple with tumor severity, albeit with an imprecise association with prognosis. Assessment of contact inhibition and differentiation-promoting culture in this study of normal and immortalized oral keratinocytes (NOK and SVpgC2a, respectively) demonstrated elevated cloning ability and saturation density in the immortalized versus normal state, including consistent absence of differentiated morphological features. Transcriptomic analysis implicated 48 gene ontology categories, 8 molecular networks, and 10 key regulator genes in confluency-induced differentiation of NOK, all of which remained nonregulated in SVpgC2a. The SVpgC2a versus NOK transcriptome enriched 52 gene ontology categories altogether, 18 molecular networks, and 39 key regulator genes, several of which were associated with epithelial-mesenchymal transition. Assessment of the previously described gene sets relative to training data sets of head and neck squamous cell carcinoma samples, one including data on tumor differentiation and patient outcome and one present in the Human Gene Expression Map, identified four genes with association to poor survival (COX7A1, MFAP5, MPDU1, and POLD1). This gene set predicted poor outcome in an independent data set of 71 head and neck squamous cell carcinomas. The present study defines, for the first time to our knowledge, the broad gene spectrum that couples to induction, and loss, of oral keratinocyte differentiation. Bioinformatics assessments of the results relative to clinical data generated novel differentiation-related tumor biomarkers relevant to patient outcome.

Citing Articles

Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer.

Zhao H, Feng K, Lei J, Shu Y, Bo L, Liu Y iScience. 2024; 27(2):108780.

PMID: 38303701 PMC: 10831879. DOI: 10.1016/j.isci.2024.108780.


Versatile knowledge guided network inference method for prioritizing key regulatory factors in multi-omics data.

Ogris C, Hu Y, Arloth J, Muller N Sci Rep. 2021; 11(1):6806.

PMID: 33762588 PMC: 7990936. DOI: 10.1038/s41598-021-85544-4.


Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma.

Zhong L, Gan X, Deng X, Shen F, Feng J, Cai W Oncol Lett. 2020; 20(3):2302-2310.

PMID: 32782547 PMC: 7400165. DOI: 10.3892/ol.2020.11781.


Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study.

Abuderman A, Harb O, Gertallah L Contemp Oncol (Pozn). 2020; 24(2):87-95.

PMID: 32774133 PMC: 7403766. DOI: 10.5114/wo.2020.97520.


The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis.

Xing L, Mi W, Zhang Y, Tian S, Zhang Y, Qi R J Cell Mol Med. 2020; 24(17):9839-9852.

PMID: 32762026 PMC: 7520306. DOI: 10.1111/jcmm.15567.